We are live on
!
Find out more
GRA
Goehring & Rozencwajg Associates Portfolio holdings
AUM
$1.86B
1-Year Est. Return
130.26%
This Fund
S&P 500
This Quarter
Est. Return
-1.38%
1 Year Est. Return
+130.26%
3 Year Est. Return
+213.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$414M
AUM Growth
+$5.32M
(+1.3%)
Cap. Flow
+$16.2M
Cap. Flow
% of AUM
3.91%
Top 10 Holdings %
Top 10 Hldgs %
48.79%
Holding
50
New
–
Increased
47
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$4.26M |
| 2 |
Range Resources
RRC
|
+$1.31M |
| 3 |
Cameco
CCJ
|
+$1.03M |
| 4 |
EQT Corp
EQT
|
+$732K |
| 5 |
CNR
Core Natural Resources Inc
CNR
|
+$691K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$611K |
| 2 |
Noble Corp
NE
|
+$555K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 71.98% |
| 2 | Materials | 28.02% |
Similar funds
CP
WRBC
ACM
EAM
BCIM
SG
CFA
OFG
Goehring & Rozencwajg Associates's Q4 2023 Portfolio in Review
As of Q4 2023, Goehring & Rozencwajg Associates held 50 positions worth $414M, up 1.3% from $408M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Goehring & Rozencwajg Associates deployed $16.2M of net new capital in Q4 2023, adding to 47 existing holdings.
By sector, the portfolio is most concentrated in Energy at 72% of assets, down from 74% a quarter earlier, followed by Materials.
On the sell side, the largest reduction was Pioneer Natural Resource Co., an estimated $611K trimmed.
- Goehring & Rozencwajg Associates added most to Nutrien in Q4 2023, an estimated $4.26M increase.
- Goehring & Rozencwajg Associates's biggest Q4 2023 reduction was Pioneer Natural Resource Co., cutting an estimated $611K.
- Goehring & Rozencwajg Associates's ten largest holdings make up 49% of its $414M portfolio in Q4 2023.
- Goehring & Rozencwajg Associates opened 0 new positions and closed 0 in Q4 2023.
- Goehring & Rozencwajg Associates's portfolio value rose 1.3% quarter-over-quarter to $414M.
Based on Goehring & Rozencwajg Associates's 13F filing for Q4 2023, filed 14 Feb 2024.